A dose-response analysis of the behavioral effects of (+)MK-801 in guinea pig: Comparison with CPP

Pharmacology Biochemistry and Behavior

Volumn 53, Issue 4, 1996, Pages 799-807

  Jerram, Annabelle H ^a   Smith, Paul F ^a,b   Darlington, Cynthia L ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

(+)MK 801; CPP; Guinea pig; NMDA antagonists; NMDA receptors

Indexed keywords

3 (2 CARBOXYPIPERAZIN 4 YL)PROLYL 1 PHOSPHONIC ACID; ANTICONVULSIVE AGENT; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROPROTECTIVE AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; ATAXIA; BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; GUINEA PIG; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; NONHUMAN; PRIORITY JOURNAL; RIGHTING REFLEX; STEREOTYPY;

ANIMALIA; ATAXIA; CAVIA PORCELLUS; COLUMBA; MACACA MULATTA; SUS SCROFA;

EID: 0029918950     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)02075-6     Document Type: Article

References (32)

1. Boast, C. A.; Gerhardt, S. C.; Pastor, G.; Lehmann, J.; Etiene, P. E.; Liebman, J. M. The N-methyl-D-aspartate antagonists CGS 19755 and CPP reduce ischemic brain damage in gerbils. Brain Res. 442:345-348; 1988.
2. Calne, D. B. Glutamate and epilepsy: Theories and therapeutics. Neurology 44(Suppl. 8):S5-S6; 1994.
3. Carlsson, M.; Svensson, A. Interfering with glutamatergic neurotransmission by means of NMDA antagonist administration discloses the locomotor stimulatory potential of other transmitter systems. Pharmacol. Biochem. Behav. 36:45-50; 1990.
4. Collingridge, G. L.; Lester, R. A. J. Excitatory amino acid receptors in the vertebrate central nervous system. Pharmacol. Revs. 40:143-210; 1989.
5. Contreras, P. C.; Contreras, M. L.; O'Donohue, T. L.; Lair, C. C. Biochemical and behavioral effects of sigma and PCP ligands. Synapse 2:240-243; 1988.
6. Corbett, D.; Evans, S.; Thomas, C.; Wang, D.; Jonas, R. A. MK-801 reduced cerebral ischemic injury by inducing hypothermia. Brain Res. 514:300-304; 1990.
7. Darlington, C. L.; Smith, P. F. The effects of N-methyl-D-aspartate antagonists on the development of vestibular compensation in the guinea pig. Eur. J. Pharmacol. 174:273-278; 1989.
8. 3H]D-AP5 binding sites on brain membranes and anticonvulsant activity. Brain Res. 383:169-173; 1986.
9. Dingwall, B.; Reeve, B.; Hutchinson, M.; Smith, P. F.; Darlington, C. L. The tolerometer: A fast, automated method for the measurement of righting reflex latency in chronic drug studies. J. Neurosci. Methods 48:111-114; 1993.
10. Ellison, G. The N-methyl-D-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias. Brain Res. Rev. 20:250-267; 1995.
11. Hargreaves, E. L.; Cain, D. P. MK-801-induced hyperactivity: Duration of effects in rats. Pharmacol. Biochem. Behav. 51:13-19; 1995.
12. Harris, E. W.; Ganong, A. H.; Monaghan, J. C.; Watkins, J. C.; Cotman, C. W. Action of (3-(±)-2-carboxypiperazin-4-yl)-propyl-1 phosphonic acid (CPP): A new and highly potent antagonist of the N-methyl-D-aspartate receptor in the hippocampus. Brain Res. 383:174-180; 1986.
13. Hiramatsu, M.; Cho, A. K.; Nabeshima, T. Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine. Eur. J. Pharmacol. 166:359-366; 1989.
14. Ishimaru, M.; Kurumaji, A.; Toru, M. Increases in strychnine-insensitive glycine binding sites in cerebral cortex of chronic schizophrenics: Evidence for glutamate hypothesis. Biol. Psychiatry 35:84-95; 1994.
15. Javitt, D. C.; Zukin, S. R. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry 148:1301-1308; 1991.
16. Kemp, J. A.; Foster, A. C.; Wong, E. H. F. Noncompetitive antagonists of excitatory amino acid receptors. Trends Neurosci. 10:294-298; 1987.
17. Kim, J. S.; Kornhuber, H. H.; Schmid-Burgk, W.; Holzmuller, B. Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci. Lett. 20:379-382; 1980.
18. Koek, W.; Woods, J. H.; Winger, G. D. MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys. J. Pharmacol. Exp. Ther. 245: 969-980; 1988.
19. Lahti, A. C.; Holcomb, H. H.; Medoff, D. R.; Tamminga, C. A. Ketamine activates psychosis and alters limbic blood flow in schizophrenia. Neuroreport 6:869-872; 1995.
20. Lodge, D.; Johnson, K. M. Noncompetitive excitatory amino acid receptor antagonists, Trends Pharmacol. Sci. 11:81-86; 1990.
21. Marquis, K. L.; Paquette, N. C.; Gussio, R. P.; Moreton, J. E. Comparative electroencephalographic and behavioral effects of phencyclidine, (+)-SKF-10,047 and MK-801 in rats. J. Pharmacol. Exp. Ther. 251:1104-1112; 1989.
22. McBain, C. J.; Mayer, M. L. N-methyl-D-aspartic acid receptor structure and function. Physiol. Rev. 74:723-760; 1994.
23. Meldrum, B. S. The role of glutamate in epilepsy and other CNS disorders. Neurology 44(Suppl. 8):S14-S23; 1994.
24. Olney, J. W.; Labruyere, J.; Price, M. T. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244:1360-1362; 1989.
25. Sansom, A. J.; Darlington, C. L.; Smith, P. F. Intraventricular administration of an N-methyl-D-aspartate receptor antagonist disrupts vestibular compensation. Neuropharmacology 29:83-84; 1990.
26. Smith, P. F.; Darlington, C. L. The NMDA antagonists MK-801 and CPP disrupt compensation for unilateral labyrinthectomy in the guinea pig. Neurosci. Lett. 94:309-313; 1988.
27. Snedecor, G. W.; Cochran, W. G. Statistical methods, 8th ed. Ames, IA: Iowa State University Press; 1989.
28. Sturgeon, R. D.; Fessler, R. G.; Meltzer, H. Y. Behavioral rating scales for assessing phencyclidine-induced locomotor activity, stereotyped behavior and ataxia in rats. Eur. J. Pharmacol. 59: 169-179; 1979.
29. Tan, S.; Kirk, R. C.; Abraham, W. C.; McNaughton, N. Effects of the NMDA antagonists CPP and MK-801 on delayed conditional discrimination. Psychopharmacology (Berlin) 98:556-560; 1989.
30. Turski, L.; Klockgether, T.; Sontag, K. H.; Herrling, P. L.; Watkins, J. C. Muscle relaxant and anticonvulsant activity of (3-(±)-2-carboxypiperazin-4-yl)-propyl-1 phosphonic acid, a novel N-methyl-D-aspartate antagonist, in rodents. Neurosci. Lett. 73: 143-148; 1987.
31. Uematsu, D.; Araki, N.; Greenberg, J. H.; Sladky, J.; Reivich, M. Combined therapy with MK-801 and nimodipine for protection of ischemic brain damage. Neurology 41:88-94; 1991.
32. Wong, E. H. F.; Kemp, J. A.; Priestley, T.; Knight, A. R.; Woodruff, G. N. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc. Natl. Acad. Sci. USA 83: 7104-7108; 1986.